Patients undergoing coronary artery bypass surgery. Atherosclerotic heart disease of native coronary artery
Conditions
Interventions
Intervention 1: Intervention group: After introducing the study and stating its objectives, if desired, the patients will complete the informed consent form, the demographic information form, the drug
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Reading and writing literacy Patients after coronary artery bypass graft Desire to participate in the study Performing coronary artery bypass graft surgery for the first time Ejection fraction above 35% Physical ability to perform exercise test Access to a smartphone Internet access
Exclusion criteria
Exclusion criteria: Heart Failure class III and IV Presence of severe musculoskeletal problems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-efficacy. Timepoint: Before, immediately after, and 3 months after the end of the intervention. Method of measurement: Using the cardiovascular disease management self-efficacy questionnaire of Steca et alii: The cardiovascular disease management self-efficacy questionnaire was designed and compiled by Steca et alii in 2015 to measure the self-efficacy of cardiovascular disease management. This questionnaire has 9 questions and 3 components of heart risk self-efficacy, treatment adherence self-efficacy, and symptom recognition self-efficacy. It is based on the Likert spectrum with questions such as (you can avoid life problems and difficult situations and daily stress well) Minimize stress well.). It measures the self-efficacy of cardiovascular disease management. The distribution of questionnaire questions is such that questions 1 to 4 examine the self-efficacy of heart risk, questions 5 and 6 examine the self-efficacy of following the treatment, and questions 7, 8, and 9 examine the self-efficacy of detecting symptoms. | — |
Secondary
| Measure | Time frame |
|---|---|
| Medication adherence. Timepoint: Before, immediately after, and 3 months after the end of the intervention. Method of measurement: Using the medication adherence reporting scale by Yan Chen et alii: The medication adherence reporting scale was compiled by Yan Chen et alii in 2019. This questionnaire contains 5 questions, and the frequency rating of each behavior in this questionnaire is based on a 5-point scale that is graded from never to always. The total score of the scale ranges from 5, which indicates the lowest level of adherence, to 25, which indicates the highest level of adherence. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGazal Veisi
Hamedan University of Medical Sciences
Outcome results
None listed